US Oncology, Inc. is a leading provider of oncology services in the United States, operating as part of The US Oncology Network. The company supports a national network of community-based cancer treatment centers, empowering independent physicians to deliver advanced, integrated cancer care close to patients' homes.
With over 25 years of expertise in oncology practice management, US Oncology facilitates access to clinical trials, pharmaceutical services, and cutting-edge technologies. It operates more than 500 cancer treatment locations, treating over 1.2 million patients annually through approximately 3,300 providers. The network emphasizes value-based care, physician satisfaction, and innovation in local oncology practices.
Headquartered in The Woodlands, Texas, and backed by McKesson Corporation, US Oncology focuses on enhancing patient outcomes and practice efficiency in the fight against cancer.
Also known as The US Oncology Network.
None yet. When a new project in the record names US Oncology as owner, partner or investor, it shows here.
Current CEO Christophe Weber will retire at the June 24 shareholder meeting; Bruce Broussard, Koichiro Kimura and Paul Stoffels proposed as new external directors; six existing externals to retire.
